$3.740
-0.093 (-2.48%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
RXRX Prediction & Forecast by Similar Chart Analysis
Alphio's RXRX stock price prediction model matches the current Recursion Pharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $3.73 (-0.21%). The 1-week path is $3.75 (+0.22%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Recursion Pharmaceuticals Inc Stock?
Recursion Pharmaceuticals Inc is a good buy right now due to its recent price increase of 5.83% over the last five days and a current price of $4.36, which is below the analyst price target of $5.50. Additionally, the stock has shown a positive momentum with an RSI of 57.036, indicating it is not overbought yet. However, investors should be cautious of the significant net loss of $131 million reported in Q2 2026, which poses a risk to future profitability.
RXRX stock price ended at $3.74 on Wednesday, after losing -2.48%
Recursion Pharmaceuticals Inc (RXRX) last closed at $3.74, losing -2.48%. These facts feed the 1-day and 1-week RXRX price prediction above.
Forecast Drivers
Recursion Pharmaceuticals Inc (RXRX) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bullish
Similar Chart Patterns
Stocks whose recent price path most closely matches RXRX, ranked by similarity.
Seasonality analysis for RXRX
Historically the probability of a positive October return for RXRX is 8.77%. January offers the highest probability of a positive month at 70.49%, while April is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for RXRX
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Oct 2026 | $4.81 | $6.43 | $7.75 | +72.02% |
| Nov 2026 | $3.30 | $4.90 | $6.52 | +31.09% |
| Dec 2026 | $5.32 | $5.57 | $6.14 | +48.95% |
In 2026, Recursion Pharmaceuticals Inc (RXRX) is projected to range from $3.30 to $7.75.
Recursion Pharmaceuticals Inc 2026 monthly forecast
In Oct 2026, Recursion Pharmaceuticals Inc is projected to average $6.43, with a low of $4.81 and high of $7.75.
In Nov 2026, Recursion Pharmaceuticals Inc is projected to average $4.90, with a low of $3.30 and high of $6.52.
In Dec 2026, Recursion Pharmaceuticals Inc is projected to average $5.57, with a low of $5.32 and high of $6.14.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.